
SXTPW
60 Degrees Pharmaceuticals Inc. Warrant
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$0.000
الأعلى
$0.000
الأدنى
$0.000
الحجم
0.00M
أساسيات الشركة
إحصاءات التداول
أخبار ذات صلة
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals
25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000A full 45 percent of persistent babesiosis cases include chronic fatigueHealthcare providers treating
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results
Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand.Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP;
أسهم ذات صلة

GREEL
Greenidge Generation Holdings Inc. 8.50% Senior Notes due 2026

CDXC
ChromaDex Corporation

VSACU
Vision Sensing Acquisition Corp. Unit

IHT
InnSuites Hospitality Trust Shares of Beneficial Interest

ZIONL
Zions Bancorporation 6.95% Fixed-to-Floating Rate Subordinated Notes
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.